These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 12189503

  • 1. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B, Eck M, Greiner A, Lührs H, Vollmers HP, Müller-Hermelink HK.
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [Abstract] [Full Text] [Related]

  • 2. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K, Kato S, Tsukui T, Sakamoto C.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [Abstract] [Full Text] [Related]

  • 3. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J, Lundin SB, Hansson LE, Sjövall H, Svennerholm AM.
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [Abstract] [Full Text] [Related]

  • 4. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
    Luzza F, Maletta M, Imeneo M, Marcheggiano A, Biancone L, Pallone F.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
    [Abstract] [Full Text] [Related]

  • 5. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 Feb; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immune response to Helicobacter pylori and cytotoxic mechanism.
    Sugiyama T, Yabana T, Yachi A.
    Scand J Gastroenterol Suppl; 1995 Feb; 208():30-2. PubMed ID: 7777802
    [Abstract] [Full Text] [Related]

  • 7. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.
    Zhang QB, Etolhi G, Dawodu JB, Gemmell CG, Russell RI.
    Clin Sci (Lond); 1999 Apr; 96(4):409-14. PubMed ID: 10087249
    [Abstract] [Full Text] [Related]

  • 8. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
    Matsukura N, Onda M, Tokunaga A, Kato S, Kyono S, Yamashita K.
    J Clin Gastroenterol; 1995 Apr; 21 Suppl 1():S146-50. PubMed ID: 8775008
    [Abstract] [Full Text] [Related]

  • 9. Adoptive transfer of splenocytes in SCID mice implicates CD4+ T cells in apoptosis and epithelial proliferation associated with Helicobacter pylori-induced gastritis.
    Peterson RA, Hoepf T, Eaton KA.
    Comp Med; 2003 Oct; 53(5):498-509. PubMed ID: 14655992
    [Abstract] [Full Text] [Related]

  • 10. Lymphoid aggregates in gastric biopsies: relationship to other mucosal lesions.
    Jaśkiewicz K, Kobierska G.
    Arch Immunol Ther Exp (Warsz); 2000 Oct; 48(3):201-4. PubMed ID: 10912626
    [Abstract] [Full Text] [Related]

  • 11. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.
    Mattsson A, Lönroth H, Quiding-Järbrink M, Svennerholm AM.
    J Clin Invest; 1998 Jul 01; 102(1):51-6. PubMed ID: 9649556
    [Abstract] [Full Text] [Related]

  • 12. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M, Sundström P, Lundgren A, Hansson M, Bäckström M, Johansson C, Enarsson K, Hermansson M, Johnsson E, Svennerholm AM.
    Clin Immunol; 2009 Jun 01; 131(3):463-71. PubMed ID: 19249247
    [Abstract] [Full Text] [Related]

  • 13. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T, Ren Z, Dunkley M, Clancy R, Maaroos HI, Labotkin R, Kull K, Uibo R.
    APMIS; 2006 May 01; 114(5):372-80. PubMed ID: 16725014
    [Abstract] [Full Text] [Related]

  • 14. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
    Manojlovic N, Nikolic L, Pilcevic D, Josifovski J, Babic D.
    Hepatogastroenterology; 2004 May 01; 51(55):282-4. PubMed ID: 15011886
    [Abstract] [Full Text] [Related]

  • 15. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
    Manojlovic N, Babic D, Filipovic-Ljeshovic I, Pilcevic D.
    Hepatogastroenterology; 2008 May 01; 55(82-83):807-13. PubMed ID: 18613460
    [Abstract] [Full Text] [Related]

  • 16. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains.
    Tinnert A, Mattsson A, Bölin I, Dalenbäck J, Hamlet A, Svennerholm AM.
    Microb Pathog; 1997 Nov 01; 23(5):285-96. PubMed ID: 9405206
    [Abstract] [Full Text] [Related]

  • 17. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 01; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori.
    Morihara F, Hifumi E, Yamada M, Nishizono A, Uda T.
    Biotechnol Bioeng; 2008 Jul 01; 100(4):634-43. PubMed ID: 18306426
    [Abstract] [Full Text] [Related]

  • 19. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 01; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

  • 20. The effect of the immune response to Helicobacter pylori in the development of intestinal metaplasia.
    Sugiyama T, Awakawa T, Hayashi S, Hisano K, Yabana T, Kurokawa I, Yachi A.
    Eur J Gastroenterol Hepatol; 1994 Dec 01; 6 Suppl 1():S89-92. PubMed ID: 7735943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.